La Crosse Method Protocol

SLIT for Peanut Allergy: What we’re learning from clinical experience

November 18, 2015

When my father, Dr. David Morris, began offering sublingual immunotherapy (SLIT) more than four decades ago, his motivation was to offer patients who were not having success with allergy injection immunotherapy another disease-modifying option. Initially, the patients who gravitated to SLIT were mold-allergic patients who were not helped by or unable to tolerate injection immunotherapy.…

Read More

Three is the Key to Development of Allergic Tolerance

October 7, 2015

Three is the key…this number holds a lot of importance in what believe makes the La Crosse Method™ Protocol safe and effective long term. First, three times a day. Every day. That’s been our daily mantra for dosing with allergy drops for decades. Many patients and providers ask why three times a day versus just…

Read More

Glycerin: The Ideal Diluent for Sublingual Immunotherapy Allergy Drops

September 23, 2015

Using the La Crosse Method™ Protocol at Allergychoices, we believe that a critical point of under the tongue delivery of the antigens for sublingual immunotherapy is the vehicle in which the antigens are suspended. Our nearly 45 year history with custom sublingual immunotherapy allergy drops, along with 195,000 patients and billions of treatment doses, has…

Read More

Why Does Sublingual Immunotherapy Work?

September 8, 2015

Drops under the tongue? How is that is going to help my allergies? I used to hear this daily from my patients and now there seems to be a seismic shift in what patients know about sublingual immunotherapy, or allergy drops, and their success in allergy treatment. Sublingual immunotherapy involves more than the gradual increasing…

Read More

La Crosse Method Reviewed

August 25, 2015

In recent years, sublingual immunotherapy has continued to gain acceptance and understanding, leading to its international recognition as a viable alternative to subcutaneous injection for allergy in both adults and children.1 With the recent FDA approval of single antigen sublingual immunotherapy tablets, even more physicians are considering, referring or offering sublingual immunotherapy for their patients.…

Read More

It’s all about the patient.

August 11, 2015

That’s been the mantra at Allergychoices since day one, when our founder Dr. David Morris decided to make a critical step. For 30 years, his La Crosse, Wisconsin, allergy practice was a destination for the typical allergy sufferers as well as “last resort” allergic patients who had tried most every treatment under the sun without…

Read More